The history of the use of radioisotopes for medical purposes is filled
with names of Nobel Prize winners. It is inspiring to read how great
minds attacked puzzling phenomena, worked out the theoretical and
practical implications of what they observed, and were rewarded by the
highest honor in science.
For example, in 1895 a German physicist, Wilhelm Konrad Roentgen,
noticed that certain crystals became luminescent when they were in the
vicinity of a highly evacuated electric-discharge tube. Objects placed
between the tube and the crystals screened out some of the invisible
radiation that caused this effect, and he observed that the greater the
density of the object so placed, the greater the screening effect. He
called this new radiation X rays, because _x_ was the standard algebraic
symbol for an unknown quantity. His discovery won him the first Nobel
Prize in physics in 1901.
[Illustration: _Wilhelm Roentgen_]
A French physicist, Antoine Henri Becquerel, newly appointed to the
chair of physics at the Ecole Polytechnique in Paris, saw that this
discovery opened up a new field for research and set to work on some of
its ramifications. One of the evident features of the production of X
rays was the fact that while they were being created, the glass of the
vacuum tube gave off a greenish phosphorescent glow. This suggested to
several physicists that substances which become phosphorescent upon
exposure to visible light might give off X rays along with the
phosphorescence.
Becquerel experimented with this by exposing various crystals to
sunlight and then placing each of them on a black paper envelope
enclosing an unexposed photographic plate. If any X rays were thus
produced, he reasoned, they would penetrate the wrapping and create a
developable spot of exposure on the plate. To his delight, he indeed
observed just this effect when he used a phosphorescent material,
uranium potassium sulfate. Then he made a confusing discovery. For
several days there was no sunshine, so he could not expose the
phosphorescent material. For no particular reason (other than that there
was nothing else to do) Becquerel developed a plate that had been in
contact with uranium material in a dark drawer, even though there had
been no phosphorescence. The telltale black spot marking the position of
the mineral nevertheless appeared on the developed plate! His conclusion
was that uranium in its normal state gave off X rays or something
similar.
[Illustration: _Henri Becquerel_]
At this point, Pierre Curie, a friend of Becquerel and also a professor
of physics in Paris, suggested to one of his graduate students, his
young bride, Marie, that she study this new phenomenon. She found that
both uranium and thorium possessed this property of radioactivity, but
also, surprisingly, that some uranium minerals were more radioactive
than uranium itself. Through a tedious series of chemical separations,
she obtained from pitchblende (a uranium ore) small amounts of two new
elements, polonium and radium, and showed that they possessed far
greater radioactivity than uranium itself. For this work Becquerel and
the two Curies were jointly awarded the Nobel Prize in physics in 1903.
[Illustration: _Pierre and Marie Curie_]
At the outset, Roentgen had noticed that although X rays passed through
human tissue without causing any immediate sensation, they definitely
affected the skin and underlying cells. Soon after exposure, it was
evident that X rays could cause redness of the skin, blistering, and
even ulceration, either in single doses or in repeated smaller doses. In
spite of the hazards[1] involved, early experimenters determined that X
rays could destroy cancer tissues more rapidly than they affected
healthy organs, so a basis was established quite soon for one of
Medicine’s few methods of curing or at least restraining cancer.
The work of the Curies in turn stimulated many studies of the effect of
radioactivity. It was not long before experimenters learned that
naturally radioactive elements—like radium—were also useful in cancer
therapy. These elements emitted gamma rays,[2] which are like X rays but
usually are even more penetrating, and their application often could be
controlled better than X rays. Slowly, over the years, reliable methods
were developed for treatment with these radioactive sources, and
instruments were designed for measuring the quantity of radiation
received by the patient.
[Illustration: _Frederic and Irene Joliot-Curie_]
The next momentous advance was made by Frederic Joliot, a French chemist
who married Irene Curie, daughter of Pierre and Marie Curie. He
discovered in 1934 that when aluminum was bombarded with alpha
particles[3] from a radioactive source, emission of positrons (positive
electrons) was induced. Moreover, the emission continued long after the
alpha source was removed. This was the first example of artificially
induced radioactivity, and it stimulated a new flood of discoveries.
Frederic and Irene Joliot-Curie won the Nobel Prize in chemistry in 1935
for this work.
Others who followed this discovery with the development of additional
ways to create artificial radioactivity were two Americans, H. Richard
Crane and C. C. Lauritsen, the British scientists, John Cockcroft and E.
T. S. Walton, and an American, Robert J. Van de Graaff. Ernest O.
Lawrence, an American physicist, invented the cyclotron (or “atom
smasher”), a powerful source of high-energy particles that induced
radioactivity in whatever target materials they impinged upon. Enrico
Fermi, an Italian physicist, seized upon the idea of using the newly
discovered neutron (an electrically neutral particle) and showed that
bombardment with neutrons also could induce radioactivity in a target
substance. Cockcroft and Walton, Lawrence, and Fermi all won Nobel
Prizes for their work.
Patient application of these new sources of bombarding particles
resulted in the creation of small quantities of hundreds of radioactive
isotopic species, each with distinctive characteristics. In turn, as we
shall see, many ways to use radioisotopes have been developed in medical
therapy, diagnosis, and research. By now, more than 3000 hospitals hold
licenses from the Atomic Energy Commission to use radioisotopes. In
addition, many thousands of doctors, dentists, and hospitals have X-ray
machines that they use for some of the same broad purposes. One of the
results of all this is that every month new uses of radioisotopes are
developed.
More persons are trained every year in methods of radioisotope use and
more manufacturers are producing and packaging radioactive materials.
This booklet tells some of the successes achieved with these materials
for medical purposes.
What Is Radiation?
Radiation is the propagation of radiant energy in the form of waves or
particles. It includes electromagnetic radiation ranging from radio
waves, infrared heat waves, visible light, ultraviolet light, and X rays
to gamma rays. It may also include beams of particles of which
electrons, positrons, neutrons, protons, deuterons, and alpha particles
are the best known.[4]
What Is Radioactivity?
It took several years following the basic discovery by Becquerel, and
the work of many investigators, to systematize the information about
this phenomenon. Radioactivity is defined as the property, possessed by
some materials, of spontaneously emitting alpha or beta particles or
gamma rays as the unstable (or radioactive) nuclei of their atoms
disintegrate.
What Are Radioisotopes?
[Illustration: _Frederick Soddy_]
In the 19th Century an Englishman, John Dalton, put forth his atomic
theory, which stated that all atoms of the same element were exactly
alike. This remained unchallenged for 100 years, until experiments by
the British chemist, Frederick Soddy, proved conclusively that the
element neon consisted of two different kinds of atoms. All were alike
in chemical behavior but some had an atomic weight (their mass relative
to other atoms) of 20 and some a weight of 22. He coined the word
_isotope_ to describe one of two or more atoms having the same atomic
number but different atomic weights.[5]
Radioisotopes are isotopes that are unstable, or radioactive, and give
off radiation spontaneously. Many radioisotopes are produced by
bombarding suitable targets with neutrons now readily available inside
atomic reactors. Some of them, however, are more satisfactorily created
by the action of protons, deuterons, or other subatomic particles that
have been given high velocities in a cyclotron or similar accelerator.
Radioactivity is a process that is practically uninfluenced by any of
the factors, such as temperature and pressure, that are used to control
the rate of chemical reactions. The rate of radioactive decay appears to
be affected only by the structure of the unstable (decaying) nucleus.
Each radioisotope has its own half-life, which is the time it takes for
one half the number of atoms present to decay. These half-lives vary
from fractions of a second to millions of years, depending only upon the
atom. We shall see that the half-life is one factor considered in
choosing a particular isotope for certain uses.
[Illustration: HALF-LIFE PATTERN OF STRONTIUM-90]
Percent of 100 50 25 12.5 6.75
Radioactivity
Beginning 1 2 3 4
of Life Half-life Half-lives Half-lives Half-lives
28 years 56 years 84 years 112 years
Most artificially made radioisotopes have relatively short half-lives.
This makes them useful in two ways. First, it means that very little
material is needed to obtain a significant number of disintegrations. It
should be evident that, with any given number of radioactive atoms, the
number of disintegrations per second will be inversely proportional to
the half-life. Second, by the time 10 half-lives have elapsed, the
number of disintegrations per second will have dwindled to ¹/₁₀₂₄ the
original number, and the amount of radioactive material is so small it
is usually no longer significant. (Note the decrease in the figure
above.)
How Are Radioisotopes Used?
A radioisotope may be used either as a source of radiation energy
(energy is _always_ released during decay), or as a tracer: an
identifying and readily detectable marker material. The location of this
material during a given treatment can be determined with a suitable
instrument even though an unweighably small amount of it is present in a
mixture with other materials. On the following pages we will discuss
medical uses of individual radioisotopes—first those used as tracers and
then those used for their energy. In general, tracers are used for
analysis and diagnosis, and radiant-energy emitters are used for
treatment (therapy).
Radioisotopes offer two advantages. First, they can be used in extremely
small amounts. As little as one-billionth of a gram can be measured with
suitable apparatus. Secondly, they can be directed to various definitely
known parts of the body. For example, radioactive sodium iodide behaves
in the body just the same as normal sodium iodide found in the iodized
salt used in many homes. The iodine concentrates in the thyroid gland
where it is converted to the hormone thyroxin. Other radioactive, or
“tagged”, atoms can be routed to bone marrow, red blood cells, the
liver, the kidneys, or made to remain in the blood stream, where they
are measured using suitable instruments.[6]
Of the three types of radiation, alpha particles (helium nuclei) are of
such low penetrating power that they cannot be used for measurement from
outside the body. Beta particles (electrons) have a moderate penetrating
power, therefore they produce useful therapeutic results in the vicinity
of their release, and they can be detected by sensitive counting
devices. Gamma rays are highly energetic, and they can be readily
detected by counters—radiation measurement devices—used outside the
body.
[Illustration: _Relative penetration of alpha, beta, and gamma
radiation._]
For comparison, a sheet of paper stops alpha particles, a block of wood
stops beta particles, and a thick concrete wall stops gamma rays.
In one way or another, the key to the usefulness of radioisotopes lies
in the energy of the radiation. When radiation is used for treatment,
the energy absorbed by the body is used either to destroy tissue,
particularly cancer, or to suppress some function of the body. Properly
calculated and applied doses of radiation can be used to produce the
desired effect with minimum side reactions. Expressed in terms of the
usual work or heat units, ergs or calories, the amount of energy
associated with a radiation dose is small. The significance lies in the
fact that this energy is released in such a way as to produce important
changes in the molecular composition of individual cells within the
body.
What Do We Mean by Tracer Atoms?
When a radioisotope is used as a tracer, the energy of the radiation
triggers the counting device, and the exact amount of energy from each
disintegrating atom is measured. This differentiates the substance being
traced from other materials naturally present.
[Illustration: _This is the first photoscanner, which was developed in
1954 at the University of Pennsylvania and was retired from service in
1963. When gamma rays emitted by a tracer isotope in the patient’s body
struck the scanner, a flashing light produced a dot on photographic
film. The intensity of the light varied with the counting rate and thus
diseased tissues that differed little from normal tissue except in their
uptake of an isotope could be discerned._]
With one conspicuous exception, it is impossible for a chemist to
distinguish any one atom of an element from another. Once ordinary salt
gets into the blood stream, for example, it normally has no
characteristic by which anyone can decide what its source was, or which
sodium atoms were added to the blood and which were already present. The
exception to this is the case in which some of the atoms are “tagged” by
being made radioactive. Then the radioactive atoms are readily
identified and their quantity can be measured with a counting device.
A radioactive tracer, it is apparent, corresponds in chemical nature and
behavior to the thing it traces. It is a true part of it, and the body
treats the tagged and untagged material in the same way. A molecule of
hemoglobin carrying a radioactive iron atom is still hemoglobin, and the
body processes affect it just as they do an untagged hemoglobin
molecule. The difference is that a scientist can use counting devices to
follow the tracer molecules wherever they go.
[Illustration: _One of the first scans made by a photoscanner. The
photorecording (dark bands), superimposed on an X-ray picture for
orientation, shows radioactivity in a cancer in the patient’s neck._]
It should be evident that tracers used in _diagnosis_—to identify
disease or improper body function—are present in such small quantities
that they are relatively harmless. Their effects are analogous to those
from the radiation that every one of us continually receives from
natural sources within and without the body. _Therapeutic_ doses—those
given for medical treatment—by contrast, are given to patients with a
disease that is in need of control, that is, the physician desires to
destroy selectively cells or tissues that are abnormal. In these cases,
therefore, the skill and experience of the attending physician must be
applied to limit the effects to the desired benefits, without damage to
healthy organs.
This booklet is devoted to these two functions of radioisotopes,
_diagnosis_ and _therapy_; the field of medical research using
radioactive tools is so large that it requires separate coverage.[7]